NEW YORK, March 29, 2018 -- The global sleeping aids market is expected to witness a CAGR of 6.8%, and is projected to reach USD 10.9 billion by 2024. The growth in the sleeping aids market is attributed to the rising incidences of sleep disorders across the globe. Moreover, growing awareness regarding the therapies for sleep disorders is also driving the growth in the sleeping aids market. The report segments Sleeping Aids market by Product (Medications, Sleep Apnea Devices, Sleep Laboratory Services, Others), Sleep Disorder (Insomnia, Sleep Apnea, Narcolepsy, Restless leg syndrome, Sleep Walking, Others), and Region (North America, Europe, Asia-Pacific, Rest of the World (RoW)). The report studies the global sleeping aids market over the forecast period (2018-2024).
The sleep aids are medications and devices which are used by people having trouble falling asleep. They include medications, sleep apnea devices, sleep laboratories, among others. A number of sleep disorders such as insomnia, restless legs,sleep apnea, narcolepsy among others can disrupt sleep quality. Disrupted sleep increases risk of obesity, diabetes, and cardiovascular diseases.
Browse full research report with TOC on “Global Sleeping Aids Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024” at: https://www.energiasmarketresearch.com/global-sleeping-aids-market-outlook/
Key findings from the report:
- The global sleeping aids market is expected to reach USD 10.9 billion by 2024
- Based on the Product , sleep apnea devices is projected to be the fastest growing segment during the forecast period
- On the basis of Sleep Disorder, the insomnia segment held the largest share of the global sleeping aids market in 2017 and is expected to retain its dominance during the forecast period
- North America held the major share of the sleeping aids market in 2017 and is projected to retain its dominance during 2018-2024
- The key players dealing in sleeping aids market are Merck & Co. Inc., Sanofi, Pfizer Inc., GlaxoSmithKline Plc, SleepMed Inc., Jazz Pharmaceuticals plc, Cadwell Industries, Inc., Natus Medical Incorporated, Drive Medical Ltd., Compumedics, among others
High Prevalence of Insomnia to Drive Global Sleeping Aids Market
Insomnia is the most common sleep disorder in the general population. Insomnia is a sleep disorder, in which people have difficulty in falling asleep or staying asleep throughout the night. Apart from cognitive therapy, sleeping pills and aids are also used frequently to treat insomnia. The incidence of insomnia is on the rise across the globe. An estimated 33% to % 50% of general population is affected by insomnia. Moreover, people over the age of 60 years are at a greater risk of insomnia. With a growing geriatric population across the globe, insomnia is projected to drive the global sleeping aids market in the forecast period.
Sleeping Aid Market - Regional insight
North America held the major share of the sleeping aids market in 2017 and is projected to retain its dominance during 2018-2024. The growth in the region is mainly driven by rising incidences of sleep disorders. The Asia-Pacific region is projected to grow at the highest CAGR during the forecast period due to growing old age population in the region.
Related Market Research Reports
- Global Cine Lens Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024
- Global Kombucha Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024
- Global Aloe Vera Extract Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024
About Energias Market Research Pvt. Ltd. -
Energias Market Research Pvt. Ltd. publishes high quality reports, in-depth market research studies, to help clients obtain investment level clarity on current business scenario, trends and segmentation for their future developments. We are committed to our client’s needs, by providing high quality custom reports solutions best fit for strategy development and implementation to high return of invest (RoI). We believe that exceptional problems need expertise to solve, and with the help of our industries expertise we are able to offer an in depth understanding of what’s crucial, what’s applicable, and what it takes to ensure accomplishment in any business or venture.
With a wide range of expertise from various industrial sectors and more than 50 industries that includes energy, chemical and materials, information communication technology, semiconductor industries, healthcare and daily consumer goods, etc. We strive to provide our clients with a one-stop solution for all research and consulting needs.
Contact Us
Alan Andrews
Business Development Manager
Phone: +1-716-239-4915
For any queries email us: [email protected]
To purchase report: [email protected]
Visit: https://www.energiasmarketresearch.com/


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Anta Sports Expands Global Footprint With Strategic Puma Stake
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



